text: Corticosteroids and human recombinant activated protein C for septic shock.
  This article summarizes the current knowledge on the benefit/risk profile from the use of low-dose corticosteroids and activated protein C in treating septic shock. Physicians should consider using low-dose corticosteroids and drotrecogin alpha activated in the treatment of patients who have vasopressor-dependent septic shock with persistent signs of hypoperfusion, organ dysfunction, or hypotension. The optimal timing for initiating these treatments is from 6 to 24 hours from onset of shock. When patients are receiving these drugs, physicians should systematically screen for superinfection and serious bleeding events.
entities.id: T1 T2 T3 T4 T5 T6
entities.type: CHEMICAL CHEMICAL CHEMICAL GENE-Y GENE-Y GENE-Y
entities.text: corticosteroids corticosteroids Corticosteroids activated protein C drotrecogin alpha human recombinant activated protein C